Search for: "Smith Drug Company, Inc" Results 181 - 200 of 390
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Oct 2014, 9:45 am by Rebecca Tushnet
Likes strong rights, but strong rights for limited numbers of marks.Cathay Smith: would it help if all marks had to show secondary meaning regardless of Abercrombiecategorization? [read post]
  In the first of these cases, Pittsburgh Press Company, the Supreme Court addressed the constitutionality of prohibiting gender-segregated classified ads (e.g. [read post]
1 Sep 2014, 7:04 am
Takeda had sought an application stating that Mylan was infringing its patented acid-reflux drug Dexilant [read post]
28 Aug 2014, 7:04 am by Joy Waltemath
Dissenting, Circuit Judge Julia Smith Gibbons would have upheld judgment as a matter of law against Dura on the issue of whether the drug testing constituted a medical exam. [read post]
6 Aug 2014, 2:34 pm
The following is a guest post from Reed Smith’s Rachel Weil. [read post]
25 Jul 2014, 1:13 pm
Cephalon, Inc., is a third party payor case where plaintiffs – workers compensation insurers – claimed that they were injured by paying for prescriptions for defendant drug company’s  pain medications which were written as a result of its alleged off-label marketing of the drug. [read post]
18 Jul 2014, 11:55 am
Smith & Nephew, 2005 WL 3470337, at *5 (M.D. [read post]
3 Jun 2014, 8:43 am by WIMS
The Panel rules: "Appellants, a group of Ecuadorian provinces and individual farmers, alleged that they were injured by an anti-drug herbicide spraying operation in Colombia, conducted by an American company. [read post]
7 Apr 2014, 5:30 am by Renee Kolar
Royal Drug Co.[6] and Union Labor Life Insurance Co. v. [read post]
3 Apr 2014, 5:00 am
Jan. 30, 2014) (“Actos”); In re Ethicon, Inc. [read post]
5 Mar 2014, 2:46 pm
  But every one of them raised serious issues that any drug/device company could find itself facing. [read post]
27 Feb 2014, 11:23 am
Omnicare, Inc., No. 12-2431, the Fourth Circuit affirmed the dismissal of a relator’s FCA complaint (and denied leave to amend) under Fed. [read post]
27 Feb 2014, 6:00 am
  We get barely more information from the characterization that there was evidence that some of defendant’s employees “were much less equivocal about the association between Zometa and ONJ than the company was indicating publicly (both via the label and via other communications with the medical community). [read post]
25 Feb 2014, 2:49 pm
The U.S. affiliate of the German Merck company was set up as an independent company in the U.S. which then became Merck, Inc.. [read post]